We previously found MHCs and presentation pathway proteins to be enriched on the surface of PDAC cell derived EVs [10] and there are multiple lines of evidence that tumor cells employ EVs to transfer MHCs loaded with tumor-derived peptides to antigen presenting cells, thereby activating anti-tumor CD8 T-cell response [47]. Here, CD8A is linked to neoplasm.